XBI Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Oct 27 at 5:06 PM ET (Korea 10/28 06:06)
Full metrics table
| Category | US Equities - Industry Sector | Expense | 0.35% | Return% 1Y | 40.49% | Total Holdings | 167 | Perf Week | 1.04% | Volume | 8,488,326 |
| Asset Type | Equities (Stocks) | AUM | $10.20B | Return% 3Y | 31.17% | NAV | $150.54 | Perf Month | -1.13% | Avg Volume | 8.86M |
| ETF Type | US Equities | Dividend TTM | $0.54 (0.35%) | Return% 5Y | 4.34% | 52W High | -8.86% | Perf Quarter | 4.69% | Rel Volume | 0.96 |
| Active/Passive | Passive | Div Gr. 3/5Y | - 9.6% | Return% 10Y | 9.86% | 52W Low | 45.66% | Perf Half Y | 18.05% | Prev Close | $150.47 |
| IPO | 2006/2/6 | Flows% 1M | 3.14% | Return% SI | 11.58% | RSI (14) | 53.39 | Perf YTD | 26.99% | Price | $154.84 |
| Beta | 0.87 | Flows% 3M | 3.95% | Flows% YTD | 6.6% | Flows% 1Y | 11.31% | Perf Year | 38.76% | Volatility(W/M) | 2.61% 2.78% |
| SMA20 | 2.32% | SMA50 | -1.4% | SMA200 | 9.69% | ATR | 4.36 | ||||
SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
The top 10 make up 18% of the fund
Spread evenly across many holdings.
APGE Apogee Therapeutics Inc 1.49% 3 
TWST Twist Bioscience Corp 1.41% 4 
MRNA Moderna Inc 1.41% 5 
ORKA Oruka Therapeutics Inc 1.38% 6 
KYMR Kymera Therapeutics Inc 1.36% 7 
VKTX Viking Therapeutics Inc 1.30% 8 
PRAX Praxis Precision Medicines Inc 1.29% 9 
ERAS Erasca Inc 1.27% 10 
RYTM Rhythm Pharmaceuticals Inc 1.20% Largest sectors first.
Over the past 1 year, on the higher side
9% below its 1-year high.
Traded about as much as usual. That is 96% of its average volume.
Holding long would have paid off
Bought 5 years ago, your return today would be +26.7%. The S&P 500 did +70% over the same period.
Tap to view numbers
The price swings a lot
At its worst (February 2021) it fell 64% and has not fully recovered yet.
Tap to view numbers
The dividend is on the small side
Pays 0.35% annually in dividends.
Tap to view numbers
Money keeps flowing in
Over the past year, new money equal to 11.3% of assets came in.
Tap to view numbers
LABU Direxion Daily S&P Biotech Bull 3X ETF 586M 
MRNY YieldMax MRNA Option Income Strategy ETF 222M 
BIB ProShares Ultra Nasdaq Biotechnology 2X Shares 96M 
LABD-1× Direxion Daily S&P Biotech Bear 3X ETF 78M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 3M 
XLV State Street Health Care Select Sector SPDR ETF 0.08% 
VHT Vanguard Health Care ETF 0.09% 
IYH iShares U.S. Healthcare ETF 0.37% 
FHLC Fidelity MSCI Health Care Index ETF 0.08% 
IHI iShares U.S. Medical Devices ETF 0.37% 
SCHH Schwab U.S. REIT ETF 0.07% 
XLK State Street Technology Select Sector SPDR ETF 0.08% 
XLF State Street Financial Select Sector SPDR ETF 0.08% 
FAQ
How many holdings does XBI have?
XBI holds a total of 167 securities, with an AUM of approximately $10.2B.
Does XBI pay dividends (distributions)?
XBI's distribution yield is approximately 0.35%.
What is the 52-week high and low for XBI?
XBI has recorded a 52-week high of $169.89 and a low of $106.30.
